Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ARCK

Arbor Rapha Capital Bioholdings Corp. I (ARCK) Stock Price, News & Analysis

Arbor Rapha Capital Bioholdings Corp. I logo

About Arbor Rapha Capital Bioholdings Corp. I Stock (NASDAQ:ARCK)

Advanced Chart

Key Stats

Today's Range
$11.90
$11.90
50-Day Range
$10.42
$15.41
52-Week Range
$9.93
$15.59
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arbor Rapha Capital Bioholdings Corp. I and its competitors with MarketBeat's FREE daily newsletter.

ARCK Stock News Headlines

DRGV Dragon Capital Group, Corp.
ECN Capital Corp. (ECNCF)
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
SuRo Capital Corp.
Ready Capital Corp.
Oxford Lane Capital Corp. (OXLC)
Deal Pro Capital Corporation (DPCC-P.V)
Quad 7 Capital
See More Headlines

ARCK Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Arbor Rapha Capital Bioholdings Corp. I investors own include Criteo (CRTO), AzurRx BioPharma (AZRX), Alnylam Pharmaceuticals (ALNY), Argos Therapeutics (ARGSQ), Editas Medicine (EDIT), abrdn Asia-Pacific Income Fund (FAX) and Weidai (WEI).

Company Calendar

Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
UNCLASSIFIED
Sub-Industry
N/A
Current Symbol
NASDAQ:ARCK
CIK
1452872
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ARCK) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners